EPISODE · Aug 21, 2026 · 32 MIN
Bonus Episode: Inside Endocyclic’s Precision Peptide Strategy For Endometriosis Diagnosis And Treatment
from Citeline Podcasts · host Norstella
One in ten women has endometriosis, yet treatment options remain largely unchanged for decades. Tanya Petrossian, CEO of EndoCyclic Therapeutics, explains how her company's non-hormonal peptide platform - now FDA-cleared for human trials - could finally change that.
Embed this episode
Ready to play
Bonus Episode: Inside Endocyclic’s Precision Peptide Strategy For Endometriosis Diagnosis And Treatment
0:00
32:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Citeline Podcasts?
This episode is 32 minutes long.
When was this Citeline Podcasts episode published?
This episode was published on August 21, 2026.
Can I download this Citeline Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!